Valuation Astellas Pharma Inc. OTC Markets

Stocks

Market Closed - OTC Markets 15:58:27 2026-10-09 EDT			5-day change	1st Jan Change
14.35 ^USD	+1.06%		-0.62%	+7.98%

10-08	Vir Biotechnology's VIR-5500 Gets FDA Fast Track Designation for Prostate Cancer	MT
10-08	Vir Biotechnology, Inc. and Astellas Pharma Inc. Announce FDAFast Track Designation for PSMA-Targeted Pro-XTEN® Dual-Masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	3,519,738	3,381,409	2,946,773	2,589,390	4,512,563	4,029,798	-	-
Change	-	-3.93%	-12.85%	-12.13%	74.27%	-10.7%	-	-
Enterprise Value (EV) ¹	3,203,752	3,004,569	2,611,086	3,232,444	4,796,910	3,970,620	3,549,144	3,173,856
Change	-	-6.22%	-13.1%	23.8%	48.4%	-17.23%	-10.61%	-10.57%
P/E	28.5x	34.7x	173x	51x	15.5x	10.5x	11x	14.3x
PBR	2.39x	2.24x	1.85x	1.71x	2.47x	1.93x	1.75x	1.65x
PEG	-	-1.8x	-2.1x	0x	0x	0.3x	-2.23x	-0.6x
Capitalization / Revenue	2.72x	2.23x	1.84x	1.35x	2.11x	1.71x	1.83x	2.06x
EV / Revenue	2.47x	1.98x	1.63x	1.69x	2.24x	1.69x	1.61x	1.62x
EV / EBITDA	13.6x	12.6x	14.2x	13.5x	8.31x	5.36x	5.11x	5.37x
EV / EBIT	20.6x	22.6x	102x	78.8x	12.5x	7.9x	7.5x	8.69x
EV / FCF	14.1x	10.3x	-3.88x	20.5x	9.72x	8.58x	6.46x	6.15x
FCF Yield	7.08%	9.7%	-25.8%	4.87%	10.3%	11.7%	15.5%	16.3%
Dividend per Share ²	50	60	70	74	78	80.15	83.08	85.31
Rate of return	2.62%	3.19%	4.26%	5.12%	3.1%	3.57%	3.7%	3.8%
EPS ²	67.08	54.24	9.51	28.35	162.8	215	204.4	157.7
Distribution rate	74.5%	111%	736%	261%	47.9%	37.3%	40.6%	54.1%
Net sales ¹	1,296,163	1,518,619	1,603,672	1,912,323	2,139,245	2,355,201	2,200,069	1,957,078
EBITDA ¹	235,370	238,767	183,358	240,171	577,227	740,639	695,004	590,976
EBIT ¹	155,686	133,029	25,518	41,039	382,633	502,606	473,427	365,400
Net income ¹	124,086	98,714	17,045	50,747	291,535	369,771	348,527	265,536
Net Debt ¹	-315,986	-376,840	-335,687	643,054	284,347	-59,179	-480,654	-855,942
Reference price ²	1,911.00	1,883.00	1,643.50	1,446.50	2,519.00	2,247.50	2,247.50	2,247.50
Nbr of stocks (in thousands)	1,841,831	1,795,756	1,792,986	1,790,107	1,791,411	1,793,014	-	-
Announcement Date	4/27/22	4/27/23	4/25/24	4/25/25	4/27/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	33.21x	12.07x	24.51x	0.59%	1,043B
JOHNSON & JOHNSON	28.53x	6.31x	18.08x	2.08%	618B
ABBVIE INC.	34.51x	8.02x	16.59x	2.55%	481B
MERCK & CO., INC.	103.58x	5.8x	24.76x	2.4%	351B
ROCHE HOLDING AG	19.03x	4.65x	11.56x	2.84%	338B
NOVARTIS AG	19.78x	5.2x	12.8x	3.06%	269B
ASTRAZENECA PLC	20.32x	4.17x	11.93x	2.13%	244B
AMGEN INC.	25.73x	6.72x	11.97x	2.48%	220B
GILEAD SCIENCES, INC.	-44.49x	6.55x	25.51x	2.24%	182B
Average	26.69x	6.61x	17.52x	2.26%	416.3B
Weighted average by Cap.	31.90x	7.75x	18.94x	1.93%